Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151

Results For "data"

1647 News Found

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


Lifebit Biotech raises US $ 60 m in Series B funding
Startup | September 30, 2021

Lifebit Biotech raises US $ 60 m in Series B funding

Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success


Wyss Center receives CE mark for Epios Cloud software
Digitisation | September 30, 2021

Wyss Center receives CE mark for Epios Cloud software

The cloud-based platform enables long-term brain monitoring towards personalized treatment


Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age


Morpen Labs carves out diagnostics business to unlock value
Diagnostic Center | September 29, 2021

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India


Eisai initiates rolling submission for Biological Licence Application of Lecanemab
Biotech | September 28, 2021

Eisai initiates rolling submission for Biological Licence Application of Lecanemab

The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
Drug Approval | September 28, 2021

Tavneos (avacopan) approved for ANCA associated vasculitis in Japan

It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan


B2B pharma start-up MEDdelivery raises US $ 1 million
Startup | September 28, 2021

B2B pharma start-up MEDdelivery raises US $ 1 million

The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months


Fujifilm to verify effectiveness of AI technology in health screening services
Digitisation | September 27, 2021

Fujifilm to verify effectiveness of AI technology in health screening services

This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year